Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The *eukaryotic translation termination factor 1 pseudogene* is a processed pseudogene that shares sequence similarity with the protein-coding ETF1 gene, which encodes eukaryotic peptide chain release factor 1 (eRF1). Pseudogenes such as this do not encode functional proteins due to disabling mutations, truncated coding sequences, or loss of regulatory regions. While the functional ETF1 is a critical component of the translation termination machinery in eukaryotic cells, pseudogenes are typically regarded as nonfunctional relics with no direct biological activity. However, some pseudogenes can have minor roles in gene regulation via RNA molecules, but there is no supporting evidence for such a function for ENSG00000251492. The name "ETF1P1" adheres to standard pseudogene nomenclature and indicates it is a homolog of the ETF1 gene. As a pseudogene, it is neither an enzyme, receptor, transporter, nor any of the classical molecular target families for drug development. It is not considered a biomarker or associated with disease etiology or therapy, and no drugs are known or expected to interact with it. Summary: ENSG00000251492 is a processed pseudogene of the Eukaryotic translation termination factor 1 (ETF1) gene. It does not code for a functional protein, is not considered a therapeutic target, and holds no disease or pharmacological significance.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation termination factor 1 pseudogene (ETF1P1).